Description:

Southwest Oncology Group Registration Form (S0226) S0226 Anastrozole With or Without Fulvestrant as First-Line Therapy in Postmenopausal Women With Metastatic Breast Cancer NCT00075764 Source Form: NCI FormBuilder: https://formbuilder.nci.nih.gov/FormBuilder/formDetailsAction.do?method=getFormDetails&formIdSeq=C3225DE6-8BA0-26CF-E034-0003BA12F5E7

Link:

https://formbuilder.nci.nih.gov/FormBuilder/formDetailsAction.do?method=getFormDetails&formIdSeq=C3225DE6-8BA0-26CF-E034-0003BA12F5E7

Keywords:
Versions (3) ▾
  1. 8/26/12
  2. 4/24/15
  3. 9/27/21
Uploaded on:

September 27, 2021

DOI:
No DOI assigned. To request one please log in.
License:
Creative Commons BY-NC 3.0 Legacy
Model comments:

You can comment on the data model here. Via the speech bubbles at the itemgroups and items you can add comments to those specificially.

Itemgroup comments for:

Item comments for:

In order to download data models you must be logged in. Please log in or register for free.

Breast Cancer Registration SWOG S0226 NCT00075764

No Instruction available.

  1. StudyEvent: Southwest Oncology Group Registration Form (S0226)
    1. No Instruction available.
Header
Method of Payment
Patient data
Patient Gender
Patient's Ethnicity
Patient's Race
Prior adjuvant tamoxifen therapy
Consent
My tissue may be kept for use in research to learn about, prevent, treat, or cure cancer.
My tissue may be kept for research about other health problems
Someone from Southwest Oncology Group may contact me in the future to ask me to take part in more research
I agree to allow my study doctor, or someone approved by my study doctor, to contact me regard future research involving my participation in this study
I agree to submit blood samples for the purpose of determining how my body metabolizes the drugs, fulvestrant and anastrozole
I agree to submit blood samples for the analysis of human epidermal growth factor receptor 2 (HER-2) protein to see if high levels will predict if I am less likely to respond to hormone therapy
I agree to submit a blood specimen for genetic expression studies to study what role the protocol treatment is having on my disease
I agree to submit a tissue specimen for the analysis of estrogen receptor (ER) and human epidermal growth factor receptor 2 (HER-2) to see if certain levels will predict if I am likely to respond to hormone therapy

Similar models